Bharat Immunologicals Financial Statements Trends

BIBCL -- India Stock  

INR 19.75  0.70  3.67%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Book Value Per Share Analysis

Book Value per Share (B/S) is can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing effects of liabilities. In other words a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of liquidation.
Bharat Immunologicals 
Book Value per Share 
 = 
Common Equity 
Average Shares 
 = 
8.63 times

About Book Value Per Share

The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as good will, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Compare to competition
In accordance with recently published financial statements the book value per share of Bharat Immunologicals Biologicals Corp Ltd is about 8.63 times. This is much higher than that of the Healthcare sector, and significantly higher than that of Book Value Per Share industry, The Book Value Per Share for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in profit margin category among related companies. It is rated below average in price to sales category among related companies fabricating about  2.66  of Price to Sales per Profit Margin.

Peer Comparison

Bharat Immunologicals Book Value Per Share Comparison
Bharat Immunologicals is currently under evaluation in book value per share category among related companies.

Did you try this?

Run Money Managers Now
   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also analysis of Bharat Immunologicals Correlation with competitors. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.